{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:17:09Z","timestamp":1782505029859,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/leu.2017.269","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T06:40:22Z","timestamp":1503384022000},"page":"224-226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo"],"prefix":"10.1038","volume":"32","author":[{"given":"N","family":"Jyotsana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Scherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Kuchenbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Sajti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Barchanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Noyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K-W","family":"S\u00fchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Grote-Koska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-P","family":"Vornlocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Stanulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Bornhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-P","family":"Bourquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Thol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ganser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R K","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Cullis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Heuser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"key":"BFleu2017269_CR1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1208760","volume":"369","author":"T Coelho","year":"2013","unstructured":"Coelho T, Adams D, Silva A, Lozeron P, Hawkins PN, Mant T et al. Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med 2013; 369: 819\u2013829.","journal-title":"N Engl J Med"},{"key":"BFleu2017269_CR2","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1056\/NEJMoa1609243","volume":"376","author":"K Fitzgerald","year":"2017","unstructured":"Fitzgerald K, Kallend D, Simon A . A highly durable RNAi therapeutic inhibitor of PCSK9. N Engl J Med 2017; 376: e38.","journal-title":"N Engl J Med"},{"key":"BFleu2017269_CR3","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1038\/mtna.2013.65","volume":"2","author":"RL Rungta","year":"2013","unstructured":"Rungta RL, Choi HB, Lin PJ, Ko RW, Ashby D, Nair J et al. Lipid nanoparticle delivery of siRNA to silence neuronal gene expression in the brain. Mol Ther Nucleic Acids 2013; 2: e136.","journal-title":"Mol Ther Nucleic Acids"},{"key":"BFleu2017269_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrc2091","volume":"7","author":"F Mitelman","year":"2007","unstructured":"Mitelman F, Johansson B, Mertens F . The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 2007; 7: 233\u2013245.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2017269_CR5","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJMra1400972","volume":"373","author":"SP Hunger","year":"2015","unstructured":"Hunger SP, Mullighan CG . Acute lymphoblastic leukemia in children. N Engl J Med 2015; 373: 1541\u20131552.","journal-title":"N Engl J Med"},{"key":"BFleu2017269_CR6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ymthe.2006.04.010","volume":"14","author":"KA Howard","year":"2006","unstructured":"Howard KA, Rahbek UL, Liu X, Damgaard CK, Glud SZ, Andersen MO et al. RNA interference in vitro and in vivo using a novel chitosan\/siRNA nanoparticle system. Mol Ther 2006; 14: 476\u2013484.","journal-title":"Mol Ther"},{"key":"BFleu2017269_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1476-4598-13-27","volume":"13","author":"KK Fleischmann","year":"2014","unstructured":"Fleischmann KK, Pagel P, Schmid I, Roscher AA . RNAi-mediated silencing of MLL-AF9 reveals leukemia-associated downstream targets and processes. Mol Cancer 2014; 13: 27.","journal-title":"Mol Cancer"},{"key":"BFleu2017269_CR8","first-page":"823","volume":"36","author":"S Takenaka","year":"2010","unstructured":"Takenaka S, Naka N, Araki N, Hashimoto N, Ueda T, Yoshioka K et al. Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo. Int J Oncol 2010; 36: 823\u2013831.","journal-title":"Int J Oncol"},{"key":"BFleu2017269_CR9","doi-asserted-by":"publisher","first-page":"e0125277","DOI":"10.1371\/journal.pone.0125277","volume":"10","author":"G Urbinati","year":"2015","unstructured":"Urbinati G, Ali HM, Rousseau Q, Chapuis H, Desmaele D, Couvreur P et al. Antineoplastic effects of siRNA against TMPRSS2-ERG junction oncogene in prostate cancer. PLoS ONE 2015; 10: e0125277.","journal-title":"PLoS ONE"},{"key":"BFleu2017269_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10238-007-0125-z","volume":"7","author":"M Koldehoff","year":"2007","unstructured":"Koldehoff M, Steckel NK, Beelen DW, Elmaagacli AH . Therapeutic application of small interfering RNA directed against bcr-abl transcripts to a patient with imatinib-resistant chronic myeloid leukaemia. Clin Exp Med 2007; 7: 47\u201355.","journal-title":"Clin Exp Med"},{"key":"BFleu2017269_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/9781118795569","volume-title":"Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells","author":"SMF Heim","year":"2015","unstructured":"Heim SMF . Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells,4th edn.Wiley-Blackwell, 2015."},{"key":"BFleu2017269_CR12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3109\/10428194.2011.565436","volume":"52","author":"MS Felice","year":"2011","unstructured":"Felice MS, Gallego MS, Alonso CN, Alfaro EM, Guitter MR, Bernasconi AR et al. Prognostic impact of t(1;19)\/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Munster-based protocols. Leuk Lymphoma 2011; 52: 1215\u20131221.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2017269_CR13","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/ng.3362","volume":"47","author":"U Fischer","year":"2015","unstructured":"Fischer U, Forster M, Rinaldi A, Risch T, Sungalee S, Warnatz HJ et al. Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options. Nat Genet 2015; 47: 1020\u20131029.","journal-title":"Nat Genet"},{"key":"BFleu2017269_CR14","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.1073\/pnas.1519273113","volume":"113","author":"S Weinstein","year":"2016","unstructured":"Weinstein S, Toker IA, Emmanuel R, Ramishetti S, Hazan-Halevy I, Rosenblum D et al. Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies. Proc Natl Acad Sci USA 2016; 113: E16\u2013E22.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2017269_CR15","first-page":"814208","volume":"2014","author":"SE Jin","year":"2014","unstructured":"Jin SE, Jin HE, Hong SS . Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics. Biomed Res Int 2014; 2014: 814208.","journal-title":"Biomed Res Int"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/leu2017269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2017269","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/leu.2017.269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/leu2017269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:09:25Z","timestamp":1684433365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2017269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["BFleu2017269"],"URL":"https:\/\/doi.org\/10.1038\/leu.2017.269","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,22]]},"assertion":[{"value":"22 August 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Euan Ramsay is an employee of Precision Nanosystems. Pieter Cullis is founder of Precision Nanosystems. The other authors have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}